Grants and Contributions:
Title:
Development of the manufacturing and encapsulation process for CaPre
Agreement Number:
933064
Agreement Value:
$326,357.00
Agreement Date:
Jul 1, 2019 - Aug 28, 2020
Description:
The project involves the commercial scale-up of certain components of the CaPre manufacturing process and aims to achieve a level of production capable of meeting the expected demand at the time of commercialization.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Laval, Quebec, CA H7T 0A3
Reference Number:
172-2019-2020-Q2-933064
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
864885652
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by -203 days. The total amended value is -423,643 dollars.
Amendment Date
Oct 29, 2020
Recipient's Legal Name:
Acasti Pharma Inc
Federal Riding Name:
Vimy
Federal Riding Number:
24078
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
325410
Amendments: